Nordea Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $147M | Sell |
1,629,844
-395,043
| -20% | -$33.1M | 0.12% | 170 |
|
|
2026
Q1 | $158M | Sell |
2,024,887
-1,617,731
| -44% | -$133M | 0.15% | 152 |
|
|
2025
Q4 | $313M | Sell |
3,642,618
-604,346
| -14% | -$49.6M | 0.27% | 95 |
|
|
2025
Q3 | $329M | Sell |
4,246,964
-110,464
| -3% | -$8.63M | 0.29% | 93 |
|
|
2025
Q2 | $339M | Sell |
4,357,428
-554,262
| -11% | -$41.3M | 0.31% | 85 |
|
|
2025
Q1 | $353M | Buy |
4,911,690
+854,677
| +21% | +$61.2M | 0.37% | 71 |
|
|
2024
Q4 | $301M | Buy |
4,057,013
+1,043,484
| +35% | +$73M | 0.32% | 84 |
|
|
2024
Q3 | $198M | Buy |
3,013,529
+531,360
| +21% | +$38.6M | 0.23% | 126 |
|
|
2024
Q2 | $231M | Buy |
2,482,169
+345,183
| +16% | +$30.6M | 0.27% | 105 |
|
|
2024
Q1 | $203M | Buy |
2,136,986
+526,574
| +33% | +$44.2M | 0.24% | 117 |
|
|
2023
Q4 | $123M | Buy |
1,610,412
+1,488,791
| +1,224% | +$104M | 0.16% | 163 |
|
|
2023
Q3 | $8.49M | Sell |
121,621
-2,813
| -2% | -$226K | 0.01% | 403 |
|
|
2023
Q2 | $11.7M | Sell |
124,434
-1,590
| -1% | -$138K | 0.02% | 378 |
|
|
2023
Q1 | $10.3M | Buy |
126,024
+578
| +0.5% | +$45.4K | 0.02% | 374 |
|
|
2022
Q4 | $9.29M | Sell |
125,446
-1,172
| -0.9% | -$90.3K | 0.01% | 391 |
|
|
2022
Q3 | $10.7M | Sell |
126,618
-30,187
| -19% | -$2.9M | 0.02% | 357 |
|
|
2022
Q2 | $14.8M | Sell |
156,805
-36,141
| -19% | -$3.74M | 0.02% | 322 |
|
|
2022
Q1 | $23.1M | Sell |
192,946
-9,994
| -5% | -$1.12M | 0.03% | 306 |
|
|
2021
Q4 | $26.5M | Sell |
202,940
-4,088
| -2% | -$477K | 0.03% | 305 |
|
|
2021
Q3 | $23.8M | Sell |
207,028
-5,116
| -2% | -$584K | 0.03% | 311 |
|
|
2021
Q2 | $22M | Buy |
212,144
+5,494
| +3% | +$518K | 0.03% | 317 |
|
|
2021
Q1 | $17.2M | Buy |
206,650
+4,392
| +2% | +$371K | 0.03% | 324 |
|
|
2020
Q4 | $18.5M | Buy |
202,258
+23,664
| +13% | +$1.96M | 0.03% | 314 |
|
|
2020
Q3 | $14.1M | Sell |
178,594
-110,744
| -38% | -$8.64M | 0.03% | 306 |
|
|
2020
Q2 | $19.6M | Buy |
289,338
+143,448
| +98% | +$10.2M | 0.02% | 322 |
|
|
2020
Q1 | $9.36M | Sell |
145,890
-4,134
| -3% | -$298K | 0.02% | 320 |
|
|
2019
Q4 | $11.6M | Sell |
150,024
-774,474
| -84% | -$60.5M | 0.02% | 322 |
|
|
2019
Q3 | $67.3M | Buy |
924,498
+7,278
| +0.8% | +$511K | 0.15% | 137 |
|
|
2019
Q2 | $56.5M | Buy |
917,220
+1,434
| +0.2% | +$86.7K | 0.13% | 160 |
|
|
2019
Q1 | $58.4M | Buy |
915,786
+224,580
| +32% | +$12.8M | 0.12% | 157 |
|
|
2018
Q4 | $35.3M | Buy |
691,206
+175,293
| +34% | +$8.87M | 0.08% | 190 |
|
|
2018
Q3 | $29.9M | Sell |
515,913
-59,187
| -10% | -$2.89M | 0.06% | 224 |
|
|
2018
Q2 | $27.9M | Buy |
575,100
+546,216
| +1,891% | +$25.5M | 0.07% | 201 |
|
|
2018
Q1 | $1.34M | Sell |
28,884
-387
| -1% | -$16.8K | ﹤0.01% | 804 |
|
|
2017
Q4 | $1.1M | Sell |
29,271
-1,326
| -4% | -$48.7K | ﹤0.01% | 782 |
|
|
2017
Q3 | $1.11M | Buy |
30,597
+222
| +0.7% | +$8.47K | ﹤0.01% | 773 |
|
|
2017
Q2 | $1.2M | Hold |
30,375
| – | – | ﹤0.01% | 763 |
|
|
2017
Q1 | $952K | Sell |
30,375
-1,125
| -4% | -$35.2K | ﹤0.01% | 777 |
|
|
2016
Q4 | $984K | Buy |
31,500
+753
| +2% | +$24.4K | ﹤0.01% | 757 |
|
|
2016
Q3 | $1.24M | Buy |
30,747
+1,065
| +4% | +$40.1K | ﹤0.01% | 582 |
|
|
2016
Q2 | $987K | Sell |
29,682
-579
| -2% | -$19.8K | ﹤0.01% | 542 |
|
|
2016
Q1 | $890K | Buy |
30,261
+10,197
| +51% | +$281K | ﹤0.01% | 570 |
|
|
2015
Q4 | $528K | Sell |
20,064
-1,020
| -5% | -$26.5K | ﹤0.01% | 617 |
|
|
2015
Q3 | $500K | Hold |
21,084
| – | – | ﹤0.01% | 549 |
|
|
2015
Q2 | $500K | Hold |
21,084
| – | – | ﹤0.01% | 569 |
|
|
2015
Q1 | $501K | Hold |
21,084
| – | – | ﹤0.01% | 576 |
|
|
2014
Q4 | $448K | Hold |
21,084
| – | – | ﹤0.01% | 593 |
|
|
2014
Q3 | $359K | Sell |
21,084
-27,216
| -56% | -$430K | ﹤0.01% | 637 |
|
|
2014
Q2 | $691K | Hold |
48,300
| – | – | ﹤0.01% | 606 |
|
|
2014
Q1 | $597K | Sell |
48,300
-16,944
| -26% | -$196K | ﹤0.01% | 628 |
|
|
2013
Q4 | $715K | Hold |
65,244
| – | – | ﹤0.01% | 618 |
|
|
2013
Q3 | $757K | Buy |
65,244
+1,800
| +3% | +$21.1K | ﹤0.01% | 616 |
|
|
2013
Q2 | $711K | Buy |
+63,444
| New | +$751K | ﹤0.01% | 644 |
|
Other funds holding EW
WT
SAM
Nordea Investment Management's EW Position: Q2 2026 in Review
Nordea Investment Management reduced its Edwards Lifesciences (EW) stake by 20% in Q2 2026, selling an estimated $33.1M and leaving 1,629,844 shares worth $147M. The position accounts for 0.12% of the portfolio, ranked #170.
Nordea Investment Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $353M in Q1 2025. 642 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Nordea Investment Management held 1,629,844 shares of Edwards Lifesciences worth $147M as of Q2 2026.
- Nordea Investment Management sold 395,043 Edwards Lifesciences shares in Q2 2026, an estimated $33.1M.
- Edwards Lifesciences made up 0.12% of Nordea Investment Management's portfolio in Q2 2026, its #170 holding.
- Nordea Investment Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Nordea Investment Management's Edwards Lifesciences position peaked at $353M in Q1 2025.
- 642 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.